Your browser doesn't support javascript.
loading
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8.
Port, Andreas; Shaw, Jamie V; Klopp-Schulze, Lena; Bytyqi, Afrim; Vetter, Claudia; Hussey, Elizabeth; Mammasse, Nadra; Ona, Victor; Bachmann, Angelika; Strugala, Denis; Reh, Christian; Goteti, Kosalaram.
Afiliación
  • Port A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Shaw JV; EMD Serono, Billerica, MA, USA.
  • Klopp-Schulze L; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Bytyqi A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Vetter C; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Hussey E; Nuventra, Inc., Durham, NC, USA.
  • Mammasse N; Cytel, Paris, France.
  • Ona V; EMD Serono, Billerica, MA, USA.
  • Bachmann A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Strugala D; Nuvisan GmbH, Neu-Ulm, Germany.
  • Reh C; Nuvisan GmbH, Neu-Ulm, Germany.
  • Goteti K; EMD Serono, Billerica, MA, USA.
Pharmacol Res Perspect ; 9(5): e00842, 2021 10.
Article en En | MEDLINE | ID: mdl-34414672
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor Toll-Like 7 / Receptor Toll-Like 8 / Factores Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor Toll-Like 7 / Receptor Toll-Like 8 / Factores Inmunológicos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Año: 2021 Tipo del documento: Article País de afiliación: Alemania